References
- Croft M. Co-stimulatory members of the TNFR family: keys to effective T-cell immunity? Nat Rev Immunol 2003;3:609-20. https://doi.org/10.1038/nri1148
- Watts TH, DeBenedette MA. T cell co-stimulatory molecules other than CD28. Curr Opin Immunol 1999;11:286-93. https://doi.org/10.1016/S0952-7915(99)80046-6
- DeBenedette MA, Chu NR, Pollok KE, Hurtado J, Wade WF, Kwon BS, et al. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its upregulation on M12 B lymphomas by cAMP. J Exp Med 1995; 181:985-92. https://doi.org/10.1084/jem.181.3.985
- Hurtado JC, Kim YJ, Kwon BS. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol 1997;158:2600-9.
- Mittler RS, Bailey TS, Klussman K, Trailsmith MD, Hoffmann MK. Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J Exp Med 1999;190:1535-40. https://doi.org/10.1084/jem.190.10.1535
- Melero I, Shuford WW, Newby SA, Aruffo A, Ledbetter JA, Hellstrom KE, et al. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors. Nat Med 1997;3:682-5. https://doi.org/10.1038/nm0697-682
- Halstead ES, Mueller YM, Altman JD, Katsikis PD. In vivo stimulation of CD137 broadens primary antiviral CD8+ T cell responses. Nat Immunol 2002;3:536-41 https://doi.org/10.1038/ni798
- Sun Y, Chen HM, Subudhi SK, Chen J, Koka R, Chen L, et al. Costimulatory molecule-targeted antibody therapy of a spontaneous autoimmune disease. Nat Med 2002;8:1405-13. https://doi.org/10.1038/nm1202-796
- Seo SK, Choi JH, Kim YH, Kang WJ, Park HY, Suh JH, et al. 4-1BB mediated immunotherapy of rheumatoid arthritis. Nat Med 2004;10: 1088-94. https://doi.org/10.1038/nm1107
- Lee SW, Croft M. 4-1BB as a therapeutic target for human disease. In: Grewal IS, editor. Therapeutic targets of the TNF superfamily. New York: Springer, 2010:121-9.
- Lombardi V, Singh AK, Akbari O. The role of costimulatory molecules in allergic disease and asthma. Int Arch Allergy Immunol 2010;151:179-89. https://doi.org/10.1159/000242355
- Fukushima A, Yamaguchi T, Ishida W, Fukata K, Mittler RS, Yagita H, et al. Engagement of 4-1BB inhibits the development of experimental allergic conjunctivitis in mice. J Immunol 2005;175:4897-903.
- Sun Y, Blink SE, Liu W, Lee Y, Chen B, Solway J, et al. Inhibition of Th2-mediated allergic airway inflammatory disease by CD137 costimulation. J Immunol 2006;177:814-21.
- Polte T, Foell J, Werner C, Hoymann HG, Braun A, Burdach S, et al. CD137-mediated immunotherapy for allergic asthma. J Clin Invest 2006; 116:1025-36. https://doi.org/10.1172/JCI23792
- Jang SO, Kim BJ, Yu J, Song YH, Kang MJ, Choi WA, et al. Human cytotoxic T lymphocyte-associated antigen 4-immunoglobulin fusion protein inhibits airway inflammation and hyperresponsiveness in a murine model of asthma. Korean J Asthma Allergy Clin Immunol 2008; 28:205-13.
- Curtis JL, Byrd PK, Warnock ML, Kaltreider HB. Requirement of CD4-positive T cells for cellular recruitment to the lungs of mice in response to a particulate intratracheal antigen. J Clin Invest 1991;88:1244-54. https://doi.org/10.1172/JCI115428
- Umetsu DT, McIntire JJ, Akbari O, Macaubas C, DeKruyff RH. Asthma: an epidemic of dysregulated immunity. Nat Immunol 2002;3:715-20. https://doi.org/10.1038/ni0802-715
- Guilbert TW, Morgan WJ, Zeiger RS, Mauger DT, Boehmer SJ, Szefler SJ, et al. Long-term inhaled corticosteroids in preschool children at high risk for asthma. N Engl J Med 2006;354:1985-97. https://doi.org/10.1056/NEJMoa051378
- Cho YS, Kwon B, Lee TH, Kim TB, Moon KA, La S, et al. 4-1 BB stimulation inhibits allergen-specific immunoglobulin E production and airway hyper-reactivity but partially suppresses bronchial eosinophilic inflammation in a mouse asthma model. Clin Exp Allergy 2006;36:377-85. https://doi.org/10.1111/j.1365-2222.2006.02445.x
- Kroczek R, Hamelmann E. T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies. J Allergy Clin Immunol 2005;116:906-9. https://doi.org/10.1016/j.jaci.2005.07.005
- Sumi T, Ishida W, Mittler RS, Yagita H, Taguchi O, Fukushima A. Regulatory T cells participate in 4-1BB-mediated suppression of experimental allergic conjunctivitis. Int Arch Allergy Immunol 2009;148: 305-10. https://doi.org/10.1159/000170384
Cited by
- 4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity vol.5, pp.None, 2015, https://doi.org/10.3389/fonc.2015.00117
- In Vivo 4-1BB Deficiency in Myeloid Cells Enhances Peripheral T Cell Proliferation by Increasing IL-15 vol.194, pp.4, 2011, https://doi.org/10.4049/jimmunol.1303439